HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xian-Zhong Ding Selected Research

LY 293111 (LY293111)

6/2007Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
6/2005A novel anti-pancreatic cancer agent, LY293111.
4/2005LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.
7/2004Effect of LY293111 in combination with gemcitabine in colonic cancer.
10/2002Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xian-Zhong Ding Research Topics

Disease

27Pancreatic Neoplasms (Pancreatic Cancer)
05/2011 - 01/2002
16Neoplasms (Cancer)
11/2008 - 01/2002
4Carcinogenesis
11/2007 - 08/2002
3Adenocarcinoma
08/2005 - 01/2002
2Colonic Neoplasms (Colon Cancer)
10/2008 - 07/2004
1Hypoxia (Hypoxemia)
05/2011
1Polyps
10/2008
1Wounds and Injuries (Trauma)
09/2008
1Cicatrix (Scar)
09/2008
1Hypertrophic Cicatrix (Hypertrophic Scar)
09/2008
1Inflammation (Inflammations)
06/2005
1Neoplasm Metastasis (Metastasis)
04/2005
1Skin Neoplasms (Skin Cancer)
11/2002
1Prostatic Neoplasms (Prostate Cancer)
11/2002
1Breast Neoplasms (Breast Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

8Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
10/2008 - 08/2002
6Proteins (Proteins, Gene)FDA Link
05/2011 - 08/2002
6Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
06/2007 - 10/2002
5ApigeninIBA
05/2011 - 12/2006
5FlavonoidsIBA
05/2009 - 01/2005
5Arachidonic Acid (Vitamin F)IBA
11/2007 - 09/2002
5LY 293111 (LY293111)IBA
06/2007 - 10/2002
5Leukotriene B4IBA
06/2007 - 08/2002
4GemcitabineFDA Link
05/2009 - 07/2004
4Lipoxygenase InhibitorsIBA
08/2003 - 08/2002
3EnzymesIBA
05/2011 - 01/2003
3Messenger RNA (mRNA)IBA
05/2011 - 08/2002
3DNA (Deoxyribonucleic Acid)IBA
12/2006 - 09/2005
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2005 - 01/2003
3Essential Fatty AcidsIBA
07/2004 - 09/2002
2Glucose (Dextrose)FDA LinkGeneric
11/2008 - 01/2002
2WortmanninIBA
11/2008 - 01/2003
2Tissue Inhibitor of Metalloproteinase-1IBA
09/2008 - 10/2004
2Transforming Growth Factor beta (TGF-beta)IBA
12/2007 - 04/2007
2CarcinogensIBA
11/2007 - 11/2002
2OligonucleotidesIBA
04/2007 - 04/2005
2ResveratrolIBA
04/2007 - 11/2002
2Pharmaceutical PreparationsIBA
12/2006 - 06/2005
2ThymidineIBA
09/2005 - 01/2004
2Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
09/2005 - 01/2003
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2005 - 01/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2005 - 06/2005
2LeukotrienesIBA
06/2005 - 10/2002
2Phosphotransferases (Kinase)IBA
10/2004 - 01/2003
2Lipoxygenase (Lipoxygenase-1)IBA
07/2004 - 01/2003
2LipoxygenasesIBA
08/2003 - 01/2003
2Dietary Fats (Dietary Fat)IBA
09/2002 - 08/2002
2baicaleinIBA
09/2002 - 08/2002
2alpha- pentyl- 3- (2- quinolinylmethoxy)benzenemethanolIBA
09/2002 - 08/2002
1ImmunosorbentsIBA
05/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2011
1Frondanol-A5PIBA
07/2010
1GemininIBA
11/2008
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
11/2008
1Phosphatidylinositols (Phosphatidylinositol)IBA
11/2008
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
11/2008
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2008
1zileuton (Zyflo)FDA Link
10/2008
1Antisense OligonucleotidesIBA
09/2008
1Connective Tissue Growth FactorIBA
09/2008
1CollagenIBA
09/2008
1Transforming Growth Factor beta2IBA
12/2007
1Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2007
1RetinoidsIBA
12/2007
1EicosanoidsIBA
11/2007
1CytokinesIBA
04/2007
1Cyclin BIBA
12/2006
1sansalvamide AIBA
02/2006
1Peptides (Polypeptides)IBA
02/2006
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
08/2005
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2005
1PPAR gammaIBA
06/2005
15-hydroxy-6,8,11,14-eicosatetraenoic acidIBA
06/2005
1enhanced green fluorescent proteinIBA
04/2005
1Fatty Acids (Saturated Fatty Acids)IBA
08/2003
1Linoleic Acid (Linoleate)IBA
01/2003
1bisindolylmaleimide IIBA
01/2003
1AcidsIBA
01/2003
1Tyrosine Kinase InhibitorsIBA
01/2003
1GenisteinIBA
01/2003
1Tyrosine (L-Tyrosine)FDA Link
01/2003
1U 0126 (UO 126)IBA
01/2003
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
01/2003
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
01/2003
1SB 203580IBA
01/2003
1Hydroxyeicosatetraenoic Acids (HETE)IBA
01/2003
1Protein Kinase CIBA
01/2003
1Biological ProductsIBA
11/2002
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2002
1Annexin A5IBA
09/2002
1Masoprocol (Actinex)FDA Link
09/2002
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
09/2002
1Cytochromes c (Cytochrome c)IBA
08/2002
1Caspase 9IBA
08/2002
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2002
1Islet Amyloid PolypeptideIBA
01/2002

Therapy/Procedure

10Therapeutics
07/2010 - 01/2003
3Chemoprevention
11/2007 - 01/2003
1Aftercare (After-Treatment)
11/2008
1Operative Surgical Procedures
04/2005